Gufic can make moves terrificGufic Biosciences Ltd. company was founded on July 23, 1984 and is headquartered in Mumbai, India is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products. It operates through the following geographical segments: India, Africa, Asia, Europe, North America, Australia and South America.
The Negative aspects of the company are High Valuation (P.E. = 38.20), Declining annual net profit, declining cash from operations annual and FIIs are decreasing stake. The positive aspects of the company are Low debt, Zero promoter pledge, MFs are increasing stake and Promoter holding increasing.
Entry after closing above 325. Targets in the stock will be 336 and 344. Long term targets in the stock will be 357 and 365. Stop loss in the stock should be maintained at closing below 292.
The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
GUFICBIO
#GUFICBIO #ZYDUSWELL #FORTIS #AARTIDRUGS #ALKEM #GLAND #BIOCON #GUFICBIO
NSE: GUFICBIO
CMP: 227
TP: 270
SL: 205
TF: <6m
RR > ~2 times
Return > 18%
GUFICBIO THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#vimtalabs #ipcalab #lauruslabs #lalpathlab #guficbio #alkem#VIMTALABS
NSE: VIMTALABS
CMP: 461
TP: 560
SL: 410
TF: <6m
RR > 2 times
Return > 22%
THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia